Proceedings of the National Academy of Sciences · 1983 · 55 citations · 30 references
Life SciencesCell BiologyImmunologyCancer ImmunologyImmunotechnologyMonoclonal AntibodiesAntibody PurificationHybridoma TechnologyManufacturing Of Monoclonal AntibodiesMonoclonal Antibody TechnologyHuman Antibody-producing ModelsHuman Hybridoma TechnologyHybridoma EngineeringMonoclonal Antibody InductionMonoclonal Antibody SelectionPeripheral Blood Mononuclear Cell ProcessingSperm Antigens
This paper describes a simple protocol for the efficient generation of large numbers of human monoclonal antibody-producing cells. This system is based on initial limiting-dilution culture after Epstein-Barr virus exposure of highly enriched precursors selected from peripheral blood mononuclear cells. Precursors can be enriched by using rosetting or panning approaches. Antibodies to erythrocytes, a mouse mammary carcinoma, DNA, and sperm antigens, produced without any deliberate immunization, are described. Large-scale human monoclonal antibody production may be facilitated by a combination of this protocol with a human cellular fusion system. For efficient precursor analysis and short-term (2 months or more) monoclonal antibody production, however, the system described here may be sufficient.
30
EB virus-induced B lymphocyte cell lines producing specific antibody
Michael Steinitz, George Klein, SAIJI KOSKIMIES et al. · Nature · 1977 · 390 citations
Production of human hybridomas secreting antibodies to measles virus
Carlo M. Croce, Alban J. Linnenbach, William W. Hall et al. · Nature · 1980 · 309 citations
PRODUCTION OF HUMAN MONOCLONAL ANTIBODY TO RHESUS D ANTIGEN
D CRAWFORD · The Lancet · 1983 · 257 citations